Key facts
- Notable investors include Fresh.Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Longevitix
- ·The full record, as it builds
Funding rounds
No funding rounds for Longevitix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Longevitix
Developer of an AI-enabled clinical decision support platform intended for longevity and preventive care clinics. The company's software integrates data from electronic health records, specialty laboratories, wearable devices and lifestyle sources to generate clinical summaries, identify risk factors and support personalized intervention planning, adherence monitoring and evidence curation for clinicians, enabling preventive medicine clinics in the United States to deliver data-driven preventative care and manage ongoing patient engagement.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2025
- Employees
- 5
- Website
- longevitix.co/
- Ownership
- Privately Held (backing)
Longevitix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Longevitix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Longevitix in its N-PORT filings yet. We sweep new filings monthly.